<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="molecules-25-03846-t003" orientation="portrait" position="float">
 <object-id pub-id-type="pii">molecules-25-03846-t003_Table 3</object-id>
 <label>Table 3</label>
 <caption>
  <p>How important are flavonoid derivatives in human disease?</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compound</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Condition at Which It Might Be Particularly Helpful 
     <sup>a</sup>
    </th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Doses at Which It Was Tested (mg/kg Body Weight)/Type of Study</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Doses at Which It Showed Toxic Effects (mg/kg Body Weight; Oral Doses in Animals) 
     <sup>b</sup>
    </th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Daily Doses Recommended by the Dietary Supplement Retailer (mg/kg Body Weight) 
     <sup>c</sup>
    </th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Is There Clinical Evidence That It Has, or Will Have, Therapeutic Benefit in Humans?</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">quercetin</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">cancer</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">1.6–4000/animal studies
     <break/>up to 14.3 
     <sup>c</sup>/human studies
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">159</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">0.3–7.1</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Some 
     <sup>i</sup> [
     <xref rid="B27-molecules-25-03846" ref-type="bibr">27</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">kaempferol</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">cancer</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">1–200/animal studies</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">1000</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">1.4–5.7</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Very limited [
     <xref rid="B81-molecules-25-03846" ref-type="bibr">81</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">taxifolin</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">cancer</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">~ 50 mg/animal studies</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">985–1200 IP 
     <sup>d</sup>
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">0.14–0.2</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">No</td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">naringenin/
     <break/>naringin
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">CVD</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">5–200 mg/animal studies
     <break/>2.9 
     <sup>c/</sup>human studies
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">0.2</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Very limited [
     <xref rid="B82-molecules-25-03846" ref-type="bibr">82</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">apigenin</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">AD, cancer</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">7.5–50/animal studies</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Data not available</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">0.7</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">No good data [
     <xref rid="B43-molecules-25-03846" ref-type="bibr">43</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">luteolin</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">cancer, inflammatory conditions</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">10–100/animal studies</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">&gt;2500–5000</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">1.4–4.3</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">No [
     <xref rid="B83-molecules-25-03846" ref-type="bibr">83</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">myricetin</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">inflammatory conditions, diabetes</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">50–500/animal studies</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">1000 IP 
     <sup>d</sup>
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">1.4</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Limited for humans [
     <xref rid="B46-molecules-25-03846" ref-type="bibr">46</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">catechin 
     <sup>e</sup>
    </td>
    <td rowspan="3" align="center" valign="middle" colspan="1">CVD</td>
    <td rowspan="3" align="center" valign="middle" colspan="1">50–2000/animal studies
     <break/>1.4–7.1 
     <sup>c/</sup>human studies
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">&gt;10,000</td>
    <td rowspan="3" align="center" valign="middle" colspan="1">0.7–8.6</td>
    <td rowspan="3" align="center" valign="middle" colspan="1">Some 
     <sup>i</sup> [
     <xref rid="B84-molecules-25-03846" ref-type="bibr">84</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">epicatechin 
     <sup>e</sup>
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">1000</td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">epigallocatechin gallate 
     <sup>e</sup>
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">2170</td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">theaflavin 
     <sup>f</sup>
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">CVD and cancer</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">250–3000/animal studies
     <break/>1.4–7.1 
     <sup>c</sup>/human studies
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">562 IP 
     <sup>d</sup>
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">0.7–1.4</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Limited [
     <xref rid="B66-molecules-25-03846" ref-type="bibr">66</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">anthocyanins</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">diabetes</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">10–2000/animal studies
     <break/>0.3–16.4 
     <sup>c</sup>/human studies
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Data not available</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">0.02–1.4</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Limited [
     <xref rid="B85-molecules-25-03846" ref-type="bibr">85</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">pycnogenol
     <sup>® g</sup>
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">venous insufficiency</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">10–40/animal studies
     <break/>2.1–5.1 
     <sup>c/</sup>human studies
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">2000–4000</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">0.3–1.4</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Limited [
     <xref rid="B59-molecules-25-03846" ref-type="bibr">59</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">rutin</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">venous insufficiency</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">10–150/animal studies
     <break/>7.1 
     <sup>c</sup>/human studies
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">2000 IP
     <sup>d</sup>
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">usually 7.1</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Some 
     <sup>i</sup> [
     <xref rid="B71-molecules-25-03846" ref-type="bibr">71</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">daflon 
     <sup>h</sup>
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">venous insufficiency</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.1–14.2 
     <sup>c</sup>/human studies
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&gt;10,000 for diosmetin
     <break/>1000 IP 
     <sup>d</sup> for hesperidin
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.1–14.2</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Some 
     <sup>i</sup> [
     <xref rid="B74-molecules-25-03846" ref-type="bibr">74</xref>]
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>
    <sup>a</sup> AD = Alzheimer’s disease, CVD = cardiovascular disorders; 
    <sup>b</sup> data retrieved from PubChem database (
    <uri xlink:href="https://pubchem.ncbi.nlm.nih.gov/" xmlns:xlink="http://www.w3.org/1999/xlink">https://pubchem.ncbi.nlm.nih.gov/</uri>; accessed on 30 January 2020); 
    <sup>c</sup> given that the average weight of an adult human is 70 kg; 
    <sup>d</sup> intraperitoneal injection, oral data not available; 
    <sup>e</sup> usually studied and marketed as green tea catechins (GTC) or standardized green tea extracts; 
    <sup>f</sup> usually studied and marketed in the form of standardized black tea extract; 
    <sup>g</sup> chiefly composed of procyanidins; 
    <sup>h</sup> composed of diosmetin (90%) and hesperidin (~10%); 
    <sup>i</sup> more data are needed to make any reasonable conclusions.
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
